BridgeBio Pharma (BBIO) Debt to Equity (2018 - 2026)
BridgeBio Pharma's (BBIO) quarterly Debt to Equity came in at -$0.57 in Q1 2026, down 110.05% quarter-over-quarter from -$0.27 in Q4 2025.
BridgeBio Pharma (BBIO) Debt to Equity (2018 - 2026) Analysis & Trends
BridgeBio Pharma has disclosed Debt to Equity across 9 years of filings, most recently posting -$0.57 for Q1 2026.
- Debt to Equity for Q1 2026 came in at -$0.57, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.57 (changed N/A YoY), and the FY2025 annual result was -$0.27, up 27.65% from the prior year.
- Debt to Equity came in at -$0.57 for Q1 2026 at BridgeBio Pharma, down from -$0.27 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of -$0.27 in Q4 2025 to a low of -$0.57 in Q1 2026.
- The 5-year median for Debt to Equity is -$0.37 (2024), against an average of -$0.38.
- Peak annual rise in Debt to Equity reached 30.23% in 2022, while the deepest fall reached 168.62% in 2022.
- BridgeBio Pharma's Debt to Equity stood at -$0.35 in 2022, then rose by 4.1% to -$0.33 in 2023, then decreased by 12.5% to -$0.37 in 2024, then grew by 27.65% to -$0.27 in 2025, then tumbled by 110.05% to -$0.57 in 2026.
- The last three Debt to Equity figures came in at -$0.57 (Q1 2026), -$0.27 (Q4 2025), and -$0.38 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.32 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | BridgeBio Pharma | 12.90 Bn | 11.97 Bn | 184.58 Mn | -0.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.57 |
| Dec 31, 2025 | -0.27 |
| Sep 30, 2025 | -0.38 |
| Dec 31, 2024 | -0.37 |
| Sep 30, 2024 | -0.36 |
| Jun 30, 2024 | -0.40 |
| Mar 31, 2024 | -0.42 |
| Dec 31, 2023 | -0.33 |
| Sep 30, 2023 | -0.37 |
| Jun 30, 2023 | -0.33 |
| Mar 31, 2023 | -0.36 |
| Dec 31, 2022 | -0.35 |
| Sep 30, 2022 | -0.37 |
| Jun 30, 2022 | -0.41 |
| Mar 31, 2022 | -0.42 |
| Dec 31, 2021 | -0.50 |
| Sep 30, 2021 | -0.14 |
| Jun 30, 2021 | -0.22 |
| Mar 31, 2021 | -0.24 |
| Dec 31, 2020 | 0.88 |